PARD Financial Facts

Preferred stock dividends, in-kind: 0
Restructuring: 0
See Full Income Statement

Total assets: 7.74M
Accounts payable: 1.48M
See Full Balance Sheet

Poniard Pharmaceuticals, Inc. (PARD) Earnings

  |   Expand Research on PARD
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate N/A Revenue Growth Rate N/A
Average % Move 1-Wk after EPS N/A Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/18/24 Q324 N/AN/A N/A N/AN/A N/A N/A N/A
11/11/24 Q324 N/AN/A N/A N/AN/A N/A N/A N/A
10/28/24 Q324 N/AN/A N/A N/AN/A N/A N/A N/A
8/26/24 Q224 N/AN/A N/A N/AN/A N/A N/A N/A
8/12/24 Q224 N/AN/A N/A N/AN/A N/A N/A N/A
5/27/24 Q124 N/AN/A N/A N/AN/A N/A N/A N/A
5/20/24 Q124 N/AN/A N/A N/AN/A N/A N/A N/A
5/13/24 Q124 N/AN/A N/A N/AN/A N/A N/A N/A